Drug shortage Until recently, there was a shortage of FDA-approved injections that contain semaglutide, such as Ozempic
Monitoring Thyroid Function During Treatment When starting semaglutide, clinicians often check TSH, free T4, and free T3 every 612 weeks
Read more here: hubs.li/Q03YY3Fv0 The #FDA approved the first oral GLP-1 receptor agonist, semaglutide (#Wegovy pill), for chronic weight management in adults with obesity or overweight with comorbidities, offering a noninjectable alternative with significant weight loss benefits
According to altRx's own published disclosure, compounded GLP-1s are produced in FDA-regulated facilities, but the medications themselves are not FDA-approved or reviewed by the FDA for safety, effectiveness, or quality before marketing
A 5,000-gram monthly production capacity makes sure there is a supply without having to wait a long time